Oversold

DOCS

Valuation73/ 100
Cash flow & growth50/ 100
Upside potential58/ 100
Risk potential21/ 100

DOCS's valuation is historically cheap, fundamentals are above averages and the outlook is broadly stable.

Score change since last week

The score rose 5 points, mainly due to valuation and price changes. Price fell 1.4%, from $26.73 to $26.35. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 4.7 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 30.1× versus the full-history median of 48.6× shown in the valuation table, producing 78.2/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 73.4/100. The model applies a -1% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 40.8× (18-month half-life). The favorable scenario uses 36.2× PE and $0.9 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +11.2%, earnings -27.4%, operating margin -10.5 percentage points. Free cash flow is 45.7% of revenue. The business score is 49.9/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $0.91 of EPS and a 36.2× PE, suggesting a share price of about $33.06. Valuation history and outlook inform the PE.

The displayed favorable scenario is 29.3% upside, or about $33.07.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $0.70 of EPS and a 28.8× PE, suggesting a share price of about $20.13 — 21% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

DOCS vs Historical averages

MetricCurrentAverageRelative
PE30x85x65% lower
PE percentile135075% lower
EPS$0.85$0.7120% higher
FCF$299.3M$181.4M65% higher
Loading historical comparisons…

DOCS’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

DOCS Forward outlook

MetricOutlook
Forward valuationStable
Forward earningsStable
Forward revenueStable
Forward profitabilityStrongly expanding
Analyst coverageModerate
Estimate dispersionModerate

DOCS’s outlook is generally stable.

DOCS PE Valuation

Loading pe valuation table…

This table applies DOCS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

DOCS Earnings Per Share

Loading earnings per share…

This chart tracks DOCS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

DOCS Quarterly Revenue

Loading quarterly revenue…

This chart tracks DOCS's quarterly revenue over time and shows how sales are changing from year to year.

DOCS Free Cash Flow

Loading free cash flow…

This chart tracks DOCS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

DOCS Total Shares

Loading shares over time…

This chart tracks changes in DOCS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

DOCS Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

DOCS PE vs Healthcare Sector

Loading pe vs sector average…

This chart compares DOCS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

DOCS Weekly Price

Loading weekly price…

This chart uses DOCS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

DOCS Weekly Moving Averages

Loading weekly moving averages…

This chart compares DOCS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

DOCS Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.